Open access · US-GOV
via ClinicalTrials.gov Clinical trial
Long-term Effects of Expanded Hemodialysis in Reduction of Large Middle Molecules in Chronic Hemodialysis Patients: Potential Benefits to the Prevention of Sarcopenia
Authors not listed
Gangnam Severance Hospital · 2020
Abstract
The current study will investigate whether long term implementation of expanded hemodialysis (HDx) will effectively decrease serum levels of large uremic toxins and ameliorate progression of sarcopenia in patients with chronic kidney disease requiring hemodialysis.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-07-02 MST
Cite this
APA
Anonymous. (2020). Long-term Effects of Expanded Hemodialysis in Reduction of Large Middle Molecules in Chronic Hemodialysis Patients: Potential Benefits to the Prevention of Sarcopenia. <em>Gangnam Severance Hospital</em>. https://clinicaltrials.gov/study/NCT04585607
Vancouver
Anonymous. Long-term Effects of Expanded Hemodialysis in Reduction of Large Middle Molecules in Chronic Hemodialysis Patients: Potential Benefits to the Prevention of Sarcopenia. Gangnam Severance Hospital. 2020.
BibTeX
@misc{anon2020Longte,
title = {Long-term Effects of Expanded Hemodialysis in Reduction of Large Middle Molecules in Chronic Hemodialysis Patients: Potential Benefits to the Prevention of Sarcopenia},
author = {Anonymous},
journal = {Gangnam Severance Hospital},
year = {2020},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.